Proton pump inhibitors do not impair the effectiveness of metformin in patients with diabetes

Use of Antidiabetic Drugs in the U.S., 2003–2012

(2014) Christian Hampp et al.   DIABETES CARE

Glucocorticoid-Induced Hyperglycemia

(2013) Soonho Kwon et al.   AMERICAN JOURNAL OF THE MEDICAL SCIENCES

The effect of lansoprazole, an OCT inhibitor, on metformin pharmacokinetics in healthy subjects

(2013) Yi Ding et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Comparative effectiveness of oral diabetes drug combinations in reducing glycosylated hemoglobin

(2013) James H Flory et al.   Journal of Comparative Effectiveness Research

Proton Pump Inhibitor Therapy Associated with Lower Glycosylated Hemoglobin Levels in Type 2 Diabetes

(2012) M. A. Crouch et al.   Journal of the American Board of Family Medicine

Metformin pathways

(2012) Li Gong et al.   Pharmacogenetics and Genomics

Proton Pump Inhibitors Inhibit Metformin Uptake by Organic Cation Transporters (OCTs)

(2011) Anne T. Nies et al.   PLoS One

Drug-Drug Interaction Profiles of Proton Pump Inhibitors

(2010) Ryuichi Ogawa et al.   CLINICAL PHARMACOKINETICS

Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials

(2010) Naveed Sattar et al.   LANCET

Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples

(2009) Peter C. Austin   STATISTICS IN MEDICINE